Rivus Pharmaceuticals
Drug DiscoveryWebsite
Developer of controlled metabolic accelerators designed to improve cardio-metabolic health. The company improves cellular metabolism and treats the underlying cause of highly prevalent metabolic and c...
Valuation
$489M
Market implied
Share Price
N/A
Total Raised
$224M
Last Round
Early Stage VC (Series B)
Aug 2022
Latest Funding Round
Early Stage VC (Series B)
Aug 19, 2022
$132M
raised
Investors
+6 other investors